172 related articles for article (PubMed ID: 19261982)
1. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.
Patra SK; Rizzi F; Silva A; Rugina DO; Bettuzzi S
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():217-35. PubMed ID: 19261982
[TBL] [Abstract][Full Text] [Related]
2. Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.
Pajak B; Kania E; Gajkowska B; Orzechowski A
J Physiol Pharmacol; 2011 Aug; 62(4):449-59. PubMed ID: 22100846
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
[TBL] [Abstract][Full Text] [Related]
4. Tea polyphenol epigallocatechin-3-gallate associates with plasma membrane lipid rafts: lipid rafts mediate anti-allergic action of the catechin.
Tachibana H; Fujimura Y; Yamada K
Biofactors; 2004; 21(1-4):383-5. PubMed ID: 15630231
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
6. Lipid raft-associated catechin suppresses the FcepsilonRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2.
Fujimura Y; Tachibana H; Yamada K
FEBS Lett; 2004 Jan; 556(1-3):204-10. PubMed ID: 14706851
[TBL] [Abstract][Full Text] [Related]
7. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Negri A; Naponelli V; Rizzi F; Bettuzzi S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
[TBL] [Abstract][Full Text] [Related]
8. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells.
Tsukamoto S; Hirotsu K; Kumazoe M; Goto Y; Sugihara K; Suda T; Tsurudome Y; Suzuki T; Yamashita S; Kim Y; Huang Y; Yamada K; Tachibana H
Biochem J; 2012 Apr; 443(2):525-34. PubMed ID: 22257159
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
11. A-type ECG and EGCG dimers inhibit 3T3-L1 differentiation by binding to cholesterol in lipid rafts.
Zhu W; Deng X; Peng J; Zou B; Li C
J Nutr Biochem; 2017 Oct; 48():62-73. PubMed ID: 28772148
[TBL] [Abstract][Full Text] [Related]
12. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Singh BN; Shankar S; Srivastava RK
Biochem Pharmacol; 2011 Dec; 82(12):1807-21. PubMed ID: 21827739
[TBL] [Abstract][Full Text] [Related]
13. A difference between epigallocatechin-3-gallate and epicatechin-3-gallate on anti-allergic effect is dependent on their distinct distribution to lipid rafts.
Fujimura Y; Tachibana H; Kumai R; Yamada K
Biofactors; 2004; 21(1-4):133-5. PubMed ID: 15630184
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins.
Kuzuhara T; Tanabe A; Sei Y; Yamaguchi K; Suganuma M; Fujiki H
Mol Carcinog; 2007 Aug; 46(8):640-5. PubMed ID: 17440927
[TBL] [Abstract][Full Text] [Related]
15. Single GUV method reveals interaction of tea catechin (-)-epigallocatechin gallate with lipid membranes.
Tamba Y; Ohba S; Kubota M; Yoshioka H; Yoshioka H; Yamazaki M
Biophys J; 2007 May; 92(9):3178-94. PubMed ID: 17293394
[TBL] [Abstract][Full Text] [Related]
16. Quantification of ascorbyl adducts of epigallocatechin gallate and gallocatechin gallate in bottled tea beverages.
Hung WL; Wang S; Sang S; Wan X; Wang Y; Ho CT
Food Chem; 2018 Sep; 261():246-252. PubMed ID: 29739590
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
18. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
19. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
20. A lipid raft-associated 67kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression.
Fujimura Y; Yamada K; Tachibana H
Biochem Biophys Res Commun; 2005 Oct; 336(2):674-81. PubMed ID: 16140266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
